Charles Schwab’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$51.4M Buy
528,896
+239,288
+83% +$21M 0.01% 1208
2026
Q2
$24M Buy
289,608
+199,950
+223% +$10.9M ﹤0.01% 1721
2026
Q1
$3.46M Buy
89,658
+1,474
+2% +$61.3K ﹤0.01% 2554
2025
Q4
$4.1M Sell
88,184
-2,101
-2% -$101K ﹤0.01% 2538
2025
Q3
$4.43M Buy
+90,285
New +$4.72M ﹤0.01% 2496

Other funds holding HNGE

Charles Schwab's HNGE Position: Q3 2026 in Review

Charles Schwab increased its Hinge Health (HNGE) stake by 83% in Q3 2026, buying an estimated $21M and bringing the position to 528,896 shares worth $51.4M. The position accounts for 0.01% of the portfolio, ranked #1208.

Charles Schwab first reported a position in HNGE in Q3 2025 and has held it in 5 quarters since. 362 funds tracked by Wall St. Rank hold HNGE as of Q3 2026.

  • Charles Schwab held 528,896 shares of Hinge Health worth $51.4M as of Q3 2026.
  • Charles Schwab bought 239,288 Hinge Health shares in Q3 2026, an estimated $21M.
  • Hinge Health made up 0.01% of Charles Schwab's portfolio in Q3 2026, its #1208 holding.
  • Charles Schwab first reported a position in Hinge Health in Q3 2025 and has held it in 5 quarters since.
  • 362 funds tracked by Wall St. Rank held Hinge Health as of Q3 2026.

Based on Charles Schwab's 13F filing for Q3 2026, filed 16 Nov 2026.